HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephan Richter Selected Research

Stephan Richter Research Topics

Disease

8Sarcoma (Soft Tissue Sarcoma)
01/2022 - 01/2013
5Neoplasms (Cancer)
01/2022 - 01/2018
3Multiple Sclerosis
09/2021 - 05/2019
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2004 - 01/2004
2Relapsing-Remitting Multiple Sclerosis
01/2022 - 01/2021
1Acute Kidney Injury (Acute Renal Failure)
01/2022
1Margins of Excision
01/2022
1Ulcerative Colitis
01/2022
1Hemangiosarcoma (Angiosarcoma)
03/2021
1Liver Failure
03/2021
1Neutropenia
10/2020
1Febrile Neutropenia
10/2020
1Testicular Neoplasms (Testicular Cancer)
02/2020
1Pain (Aches)
01/2020
1Anorexia
01/2020
1Cachexia
01/2020
1Autoimmune Diseases (Autoimmune Disease)
05/2019
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
05/2019
1Chordoma
01/2019
1Alveolar Rhabdomyosarcoma
01/2018
1Cardiovascular Diseases (Cardiovascular Disease)
01/2017
1Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve)
12/2016
1Cardiotoxicity
01/2016
1Heart Failure
01/2016
1Leiomyosarcoma
01/2014
1Myocardial Infarction
01/2013

Drug/Important Bio-Agent (IBA)

4Pharmaceutical PreparationsIBA
01/2022 - 01/2016
3pazopanibFDA Link
01/2022 - 10/2020
2Alemtuzumab (Campath)FDA Link
01/2021 - 05/2019
2TrabectedinIBA
01/2020 - 01/2013
2AnthracyclinesIBA
01/2016 - 01/2013
2Proteins (Proteins, Gene)FDA Link
06/2004 - 01/2004
1Methotrexate (Mexate)FDA LinkGeneric
01/2022
1Sphingosine-1-Phosphate ReceptorsIBA
01/2022
1glucarpidaseIBA
01/2022
1tyrosine receptor (receptor, tyrosine)IBA
01/2022
1ozanimodIBA
01/2022
1CladribineFDA LinkGeneric
09/2021
1TabletsIBA
09/2021
1Paclitaxel (Taxol)FDA LinkGeneric
03/2021
1Monoclonal AntibodiesIBA
01/2021
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
01/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2020
1cabazitaxelFDA Link
02/2020
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
01/2020
1olaparibIBA
01/2019
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2019
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2019
1Anaplastic Lymphoma KinaseIBA
01/2018
1Tyrosine Kinase InhibitorsIBA
01/2018
1CrizotinibIBA
01/2018
1Fingolimod Hydrochloride (FTY720)FDA Link
01/2017
1Dexrazoxane (Zinecard)FDA LinkGeneric
01/2016
1GemcitabineFDA Link
01/2014
1Docetaxel (Taxotere)FDA Link
01/2014
1X-Linked Inhibitor of Apoptosis ProteinIBA
06/2004
1SurvivinIBA
06/2004
1Apoptosis Regulatory ProteinsIBA
03/2004
1Inhibitor of Apoptosis ProteinsIBA
01/2004

Therapy/Procedure

9Therapeutics
01/2022 - 03/2004
2Palliative Care (Palliative Therapy)
01/2020 - 01/2017
1Aftercare (After-Treatment)
01/2022
1Radiotherapy
01/2022
1Neoadjuvant Therapy
01/2013
1Drug Therapy (Chemotherapy)
06/2004